OBIO’s Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

OBIO® celebrates significant economic impact as it accelerates capital access for Canada’s leading health tech, medtech, and biotech innovators. TORONTO — OBIO®, a not-for-profit, membership-based organization offering strategy, programming and infrastructure to support early-stage and venture-backed companies across the therapeutics, medtech, diagnostics and digital health sectors, is celebrating a major growth milestone: companies supported through […]